We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BOI.PA

Price
22.75
Stock movement down
-0.25 (-1.09%)
Company name
Boiron SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Markedsværdi
394.99M
Ent værdi
526.35M
Pris/omsætning
0.55
Pris/bog
1.06
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
466.37%
Efterfølgende P/E
10.09
Fremtidig P/E
13.32
PEG
-
EPS-vekst
-8.57%
1 års afkast
-26.02%
3 års afkast
-19.68%
5 års afkast
-7.20%
10 års afkast
-13.72%
Senest opdateret: 2025-06-22

UDBYTTE

BOI.PA betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E10.09
Pris til OCF5.61
Pris til FCF7.94
Pris til EBITDA3.24
EV i forhold til EBITDA4.31

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning0.55
Pris til egenkapital1.06
EV i forhold til salg0.73

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier17.36M
EPS (TTM)2.26
FCF pr. aktie (TTM)2.86

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)721.60M
Bruttofortjeneste (TTM)525.78M
Driftsindkomst (TTM)45.51M
Nettoindkomst (TTM)39.16M
EPS (TTM)2.26
EPS (1 år frem)1.71

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)72.86%
Driftsmargin (TTM)6.31%
Fortjenstmargin (TTM)5.43%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter53.33M
Nettotilgodehavender77.70M
Omsætningsaktiver i alt255.65M
Goodwill89.70M
Immaterielle aktiver29.74M
Ejendomme, anlæg og udstyr0.00
Sum aktiver557.65M
Kreditor37.20M
Kortfristet/nuværende langsigtet gæld14.85M
Summen af kortfristede forpligtelser113.86M
Sum gæld184.68M
Aktionærernes egenkapital372.97M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)70.39M
Investeringsudgifter (TTM)19.79M
Fri pengestrøm (TTM)49.74M
Udbetalt udbytte (TTM)231.96M

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast10.50%
Afkast af aktiver7.02%
Afkast af investeret kapital10.31%
Kontant afkast af investeret kapital13.09%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning22.50
Daglig høj23.00
Daglig lav22.50
Daglig volumen0K
Højeste gennem alle tider111.35
1 års analytiker estimat33.30
Beta0.45
EPS (TTM)2.26
Udbytte pr. aktie-
Ex-div dato3 Jun 2025
Næste dato for resultatpræsentation-

Nedsidepotensial

Loading...
Nedsidepotensial-data
BOI.PAS&P500
Nuværende prisfald fra top notering-79.57%-3.04%
Højeste prisfald-79.61%-56.47%
Højeste efterår dato18 Jun 20259 Mar 2009
Gennemsnitlig fald fra toppen-25.71%-11.04%
Gennemsnitlig tid til nyt højdepunkt39 days12 days
Maks. tid til nyt højdepunkt2611 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
BOI.PA (Boiron SA) company logo
Markedsværdi
394.99M
Markedsværdi kategori
Small-cap
Beskrivelse
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Personale
2788
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
France
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Annual Awards Program Recognizes Innovative Companies, Services and Products Within the Baby Care IndustryLOS ANGELES, June 26, 2025 (GLOBE NEWSWIRE) -- The 2025 Baby Innovation Awards, an independent...
27. juni 2025
Newtown Square, Pennsylvania--(Newsfile Corp. - June 26, 2025) - Camilia Tummy® has received the "Baby Accessory Product of the Year" in the 2025 Baby Innovation Awards. Now in its fifth year, this in...
26. juni 2025
Polygon Labs’ product, AggLayer, aims to fix the fragmentation that has slowed growth in assets. Afra Wang meets the man making it happen.
15. april 2025
Polygon Labs CEO Marc Boiron says prediction markets like Polymarket offer faster and more accurate insights than traditional news, pointing to the 2024 U.S. elections as proof.
5. marts 2025
As European markets continue to rally, supported by slowing inflation and positive economic sentiment, investors are increasingly looking for stable opportunities amidst the broader market optimism. I...
6. september 2024
The French stock market has recently shown resilience, with the CAC 40 Index advancing by 2.48% amid growing hopes for another round of interest rate cuts. As the Eurozone economy maintains its steady...
22. august 2024
The French market has recently seen a significant decline, with the CAC 40 Index dropping 3.54% amid global concerns over weak U.S. economic data and broader growth worries. Despite this volatility, d...
7. august 2024
As of July 2024, the French market, along with other European indices, has shown resilience with the CAC 40 Index experiencing a modest rise. This positive trajectory in Europe comes amidst a broader ...
18. juli 2024